Mark Underwood

4.8k citations
56 papers · 4.1k · 3 hit papers · h-index 28

Impact in

    • HIV/AIDS drug development and treatment
    • HIV/AIDS Research and Interventions
  • Virology top 5%
    • HIV Research and Treatment

Papers in

    • HIV/AIDS drug development and treatment 44
    • Cytomegalovirus and herpesvirus research 8
    • Cervical Cancer and HPV Research 2

Mark Underwood

55 papers receiving 3.9k citations

Mark Underwood's Hit Papers

Efficacy, safety, and tolerability of dolutegravir-rilpivirine for the maintenance of virological suppression in adults with HIV-1: phase 3, randomised, non-inferiority SWORD-1 and SWORD-2 studies 2018 · 300 citations
3000+4+8Years since publication100200300400

Peers

Mark Underwood
Comparison fields: 5 of 40
  • Infectious Diseases 2.8k
  • Virology 93
  • Epidemiology 549
  • Emergency Medicine 70
  • Pharmacology 17
Replace Marshall W. Fordyce with:
Marshall W. Fordyce United States
Kirsten White United States
Sandra Nusinoff-Lehrman United States
Gordon E. Crofoot United States
Christine L. Talarico United States
Colin McLaren United States
Anthony Mills United States
Carey K. Hwang United States
Kurt Hertogs United States
Martin S. Rhee United States
Mark Underwood relative to Marshall W. Fordyce United States Marshall W. Fordyce's profile →
Citations per field
00.5×2×3.5×
Marshall W. Fordyce · 1×
Citations per year

Countries citing papers authored by Mark Underwood

Since Specialization
Citations

This map shows the geographic impact of Mark Underwood's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Underwood with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Underwood more than expected).

Fields of papers citing papers by Mark Underwood

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Underwood. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Underwood. The network helps show where Mark Underwood may publish in the future.

Co-authors

The 25 scholars most cited alongside Mark Underwood, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark Underwood Line = papers co-authored together Mark Underwood links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 56 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Dolutegravir versus raltegravir in antiretroviral-experienced, integrase-inhibitor-naive adults with HIV: week 48 results from the randomised, double-blind, non-inferiority SAILING study
Hit paper breakdown →
2013451
2 2010346
3
Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials
Hit paper breakdown →
2018313
4
Efficacy, safety, and tolerability of dolutegravir-rilpivirine for the maintenance of virological suppression in adults with HIV-1: phase 3, randomised, non-inferiority SWORD-1 and SWORD-2 studies
Hit paper breakdown →
2018300
5 2011208
6 2011198
7 2011194
8 1998180
9 1998164
10 2019157
11 2019142
12 2003137
13 2022115
14 202199
15 201993
16 199090
17 201488
18 201282
19 200764
20 199860

About Mark Underwood

Mark Underwood is a scholar working on Infectious Diseases, Epidemiology, Molecular Biology, Nuclear Energy and Engineering and Waste Management and Disposal, having authored 56 papers that have together received 4.1k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (44 papers), Cytomegalovirus and herpesvirus research (8 papers), Cervical Cancer and HPV Research (2 papers) and Nuclear Structure and Function (1 paper). The work is most often cited by research in Infectious Diseases (2.8k citations), Virology (93 citations), Epidemiology (549 citations), Emergency Medicine (70 citations) and Pharmacology (17 citations). Mark Underwood has collaborated with scholars based in United States, United Kingdom and Japan. Frequent co-authors include Tamio Fujiwara, Karen K. Biron, Leroy B. Townsend, John C. Drach, Brian A. Johns, Akihiko Sato, Takahiro Seki, Howard M. Fried, Brian Wynne and Tomokazu Yoshinaga. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, JAIDS Journal of Acquired Immune Deficiency Syndromes, Antiviral Research, Journal of Infection and Public Health and Journal of Virology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact